DERIVO® 2heal® Study: Clinical Safety and Efficacy of the DERIVO® 2heal® Embolisation Device

Clinical trial NCT05543447 · RECRUITING

Trial details

NCT number: NCT05543447
Sponsor: Acandis GmbH
Status: RECRUITING
Study type: OBSERVATIONAL

Intracranial Aneurysm Flow Diverter

Start date: 2022-12-15
Primary completion: 2025-12-01
Enrollment: 158

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.